Published date: 5 February 2016
This notice was replaced on 5 February 2016
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Future opportunity (published 23 August 2017)
Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.
Contract summary
Industry
General anti-infectives for systemic use and vaccines - 33651000
Location of contract
Any region
Value of contract
£0
Procurement reference
CM/PHV/16/5504
Published date
5 February 2016
Approach to market date
14 May 2018
Contract start date
1 June 2019
Contract end date
31 May 2021
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Meningococcal vaccine to be centrally purchased for the adolescent immunisation programme, either Men C or MenACWY dependant on policy at that time.
More information
Spend profile
| Financial year | Budget |
|---|---|
| 2019/2020 | £0 |
About the buyer
Address
Commercial Medicines Unit
2nd Floor, Rutland House
Runcorn, Cheshire
WA7 2ES
England
Share this notice
All content is available under the
